Trailing-twelve-month (TTM) revenue is $311.51 Million with a year-over-year growth of +19.76%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $73,468,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $77,114,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $77,705,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $83,220,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $311,507,000 |
Current P/S: $2,021,623,440 market capitalization ÷ $311,507,000 TTM revenue = 6.49x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $83.22M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:01:09.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| License | $50M | $117,000 | $31M | N/A | N/A | N/A |
| License, Collaboration and Royalty Revenue | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $118,000 | N/A | N/A | N/A | N/A | N/A |
| JAPAN | $50M | $0 | $31M |
$311.51M
$311.51 Million
+19.76%
vs. $260.11M a year ago (TTM)
+40.17%
5 Year compound annual growth rate
1 Year
+19.76%
3 Year
+24.83%
5 Year
+40.17%
10 Year
+106.05%
15 Year
+48.20%
20 Year
+26.26%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $283.06M | +$47.92M | +20.38% |
| 2024 | $235.13M | +$59.62M | +33.97% |
| 2023 | $175.51M | +$41.48M | +30.95% |
| 2022 | $134.03M | +$88.42M | +193.89% |
| 2021 | $45.60M | ($4.51M) | (9.00%) |
| 2020 |
TTM Growth
+19.76%
3-Year CAGR
+24.83%
5-Year CAGR
+40.17%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T12:01:09.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $17M |
| $19M |
| $12M |
| Product | $0 | $45M | $103M | $159M | $216M | $271M |
|---|
| $18M |
| $25M |
| $19M |
| Other Country | N/A | $117,000 | $89,000 | $0 | N/A | N/A |
|---|
| UNITED STATES | $0 | $45M | $102M | $158M | $210M | $264M |
|---|
| $50.12M |
| +$49.80M |
| +15660.38% |
| 2019 | $318,000 | ($145,000) | (31.32%) |
| 2018 | $463,000 | +$43,000 | +10.24% |
| 2017 | $420,000 | +$247,000 | +142.77% |
| 2016 | $173,000 | ($62,000) | (26.38%) |
